Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer - Wikidata - wikimedia - TriplyDB

Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer

Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer

http://www.wikidata.org/entity/Q28282730

about

TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu Androgen receptor molecular biology and potential targets in prostate cancer Immunotherapy in Multiple Myeloma Using Cancer-Testis Antigens Cancer/testis antigens: novel tools for discerning aggressive and non-aggressive prostate cancer Progress in immunotherapy for non-small cell lung cancer What future opportunities may immuno-oncology provide for improving the treatment of patients with lung cancer?Lung cancer vaccines Lung cancer vaccines: current status and future prospects MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer Differential evolution of MAGE genes based on expression pattern and selection pressure Monoclonal antibody MX35 detects the membrane transporter NaPi2b (SLC34A2) in human carcinomas Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1 Integrative discovery of epigenetically derepressed cancer testis antigens in NSCLC.T cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studies.Tumor subtype-specific cancer-testis antigens as potential biomarkers and immunotherapeutic targets for cancers.Targeted immunotherapy for non-small cell lung cancer.Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer.Cancer/Testis Antigens: "Smart" Biomarkers for Diagnosis and Prognosis of Prostate and Other Cancers Serum immunoreactivity of cancer/testis antigen OY-TES-1 and its tissues expression in glioma.Frequent MAGE mutations in human melanoma MAGE I transcription factors regulate KAP1 and KRAB domain zinc finger transcription factor mediated gene repression Expression and immune responses to MAGE antigens predict survival in epithelial ovarian cancer PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses Cancer-testis (CT) antigen expression in medulloblastoma.Prolonged survival of patients with lung adenocarcinoma expressing XAGE-1b and HLA class I antigens Demethylation of CpG islands in the 5' upstream regions mediates the expression of the human testis-specific gene MAGEB16 and its mouse homolog Mageb16.MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies.Immunotherapeutic Intervention against Sarcomas.High expression of MAGE-A10 cancer-testis antigen in triple-negative breast cancer.Essential gene profiles in breast, pancreatic, and ovarian cancer cells.Recent advances in immunotherapy for non-small-cell lung cancer.Derepression of Cancer/testis antigens in cancer is associated with distinct patterns of DNA hypomethylation.The cancer/testis antigen prostate-associated gene 4 (PAGE4) is a highly intrinsically disordered protein.Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma.Expression of Cancer/Testis genes in ductal carcinoma in situ and benign lesions of the breast.Cancer-testis gene expression is associated with the methylenetetrahydrofolate reductase 677 C>T polymorphism in non-small cell lung carcinoma.Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity.High expression of MAGE-A9 in tumor and stromal cells of non-small cell lung cancer was correlated with patient poor survival A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response Cancer/Testis Antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy.

P2860

Q21131200-B6C21C9A-0D07-49BE-A264-6A53A9E85ADE Q24602861-234360EE-B5BF-4EFA-BCB4-BDDCF13F6FE3 Q26774913-E61525CF-726A-4679-BC37-358496C38D75 Q26852766-257629B4-B929-4656-B870-449BF189FDBC Q26865725-06DC7E69-C6AA-401F-A275-6BBB55E73770 Q27012886-60A5894A-4A51-471A-A2BF-3F9BF776A637 Q27014375-25C8D1E0-3667-496B-9F0A-F16E5C5CFEB5 Q28080849-DD7E6C12-CE9E-4CFE-9735-16D7E5548E6F Q28478930-56050FD0-44F8-4B61-9FC3-10EBA6D6C1BC Q28714314-F2B4ECD5-7025-4D78-8454-2AB48F8AF0BF Q28972398-C1062FC8-1B65-4BC1-B356-FAD7CA3CF56F Q29616128-75114B1E-2689-4E4B-8956-CB98621EE746 Q30974053-BF3978E7-56E5-4D74-8CFB-449EEA5F081F Q33530527-F3F05F28-6A87-4150-8D07-B5BE16382582 Q33555751-B3AE1599-50E0-470B-8431-75282D5715F6 Q33585089-F555F98C-DB42-45B6-BEB1-66E20B459995 Q33599094-06369E27-6943-47B8-B8FE-ED2BEA05EA9B Q33624448-032EF3BB-4B97-4351-93C0-F5F8A84B7FC0 Q33686433-A7C7FF7E-8C64-417B-A3A6-F15B22D91EF3 Q33700477-ED459797-817E-41BB-891E-D9CB41F6B57C Q34005548-2540F9C3-72DD-4478-98D0-DA37260BBBE3 Q34015590-B50B46B3-102B-4B57-8A14-BA9CBA9C2C0C Q34111731-D55DC1AE-E31E-48A6-98EF-B4D856ABA434 Q34111864-9D64A021-5079-4A68-9D4C-0BCF212A3F11 Q34111868-C44710FE-65AD-417F-BED6-58C275ADA2FF Q34180138-D9AF21B2-C1C6-4912-B106-4D8D12F08249 Q34196069-3C6BD822-7132-4616-9D2F-A61BCEFA3C38 Q34196481-A8DFC7BB-4253-4EFC-96C3-FDF9AE2EDBCB Q34235940-EB6BE42F-D747-4BD0-93D6-4B23942AC1A6 Q34268870-27C4FC6F-75F5-4B32-9386-1A23378C74B5 Q34290801-BB5BA855-B14C-45CD-9F3C-66A9502BE787 Q34632716-8C99D21C-7B82-4678-8429-0F474C3AAC0B Q34799973-0DC12750-52D2-4ABE-93FF-014081C41DB3 Q34870799-5BC8D9D2-4CCD-4A92-B8D6-04AB98EB0411 Q34971907-CDA7BB64-00AE-42DD-8D03-F623C8CBDC74 Q34996398-4717DD29-E025-4744-87D8-9F052CBB076B Q35110486-D15276E2-217D-4598-A5D1-26EC36CA0005 Q35144956-DE2D2415-7F03-4630-A518-D2BDC99C70F7 Q35182795-F10ED110-9DD4-4A86-AE4F-DB82DCFB56A3 Q35249858-48590F97-A5FA-4FFC-A6E3-FAFA50A2159A

P2860

Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer

http://www.wikidata.org/entity/Q28282730

description

2005 nî lūn-bûn

@nan

2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Cancer-testis genes are coordi ...... in non-small cell lung cancer

@ast

Cancer-testis genes are coordi ...... in non-small cell lung cancer

@en

Cancer-testis genes are coordi ...... in non-small cell lung cancer

@nl

type

label

Cancer-testis genes are coordi ...... in non-small cell lung cancer

@ast

Cancer-testis genes are coordi ...... in non-small cell lung cancer

@en

Cancer-testis genes are coordi ...... in non-small cell lung cancer

@nl

prefLabel

Cancer-testis genes are coordi ...... in non-small cell lung cancer

@ast

Cancer-testis genes are coordi ...... in non-small cell lung cancer

@en

Cancer-testis genes are coordi ...... in non-small cell lung cancer

@nl

P1433

Q28282730-9A9C3CA5-FA2D-44EF-B95E-9CCD6CA225EB

P1476

Q28282730-AA593DEE-5020-48D9-9631-0F3412E1AB62

P2093

Q28282730-03D5AEB8-03F2-4D1D-97F4-F4CB53135A97

Q28282730-1BBA693F-54A9-4F0F-9B6A-38B22F1BDA45

Q28282730-208F7079-ECB3-432D-81F4-73D3396DD859

Q28282730-39553947-411D-47A6-87C8-9EB222D29BFE

Q28282730-436045E9-539C-44F8-9DF8-D56FA5212198

Q28282730-5D6EFDB9-45D5-4C71-9A7D-929258125362

Q28282730-8C1E240F-B43F-46B7-A3CC-FD10935682C8

Q28282730-B253A237-9ACB-4A09-9465-82880DFE0961

Q28282730-CBCF917C-12FA-4C1C-B66F-60F0F432C837

Q28282730-F31FC405-AE55-4FF6-A2B4-CBC9D69ED371

P304

Q28282730-E9C3CC30-70CA-4E6F-858E-E985A021C39E

P31

Q28282730-285D8CB8-9031-4FD5-96A1-148C60B70D46

P3181

Q28282730-B692CCD3-5257-4C27-B358-43E40F12FEF8

P356

Q28282730-68C57873-9D54-48AA-B537-BC085CF1C0D4

P407

Q28282730-CA9EF31B-3868-4818-BEA8-10EF566B3E57

P433

Q28282730-1270F3F1-C254-4966-876C-FAA4136915A1

P478

Q28282730-F48325F2-9333-47EC-98AB-E1F3C462F47B

P577

Q28282730-C0E9063F-AAF3-4A14-BD3E-4879E7E12A8B

P698

Q28282730-1823B63D-29AF-471D-9C9E-E502E5AA32A4

P3181

P356

1078-0432.CCR-05-1203

P1433

Clinical Cancer Research

P1476

Cancer-testis genes are coordi ...... in non-small cell lung cancer

@en

P2093

Ali O Gure

http://www.w3.org/2001/XMLSchema#string

Andrew J G Simpson

http://www.w3.org/2001/XMLSchema#string

Barbara Williamson

http://www.w3.org/2001/XMLSchema#string

Cathy A Ferrera

http://www.w3.org/2001/XMLSchema#string

Gerd Ritter

http://www.w3.org/2001/XMLSchema#string

Lloyd J Old

http://www.w3.org/2001/XMLSchema#string

Mithat Gonen

http://www.w3.org/2001/XMLSchema#string

Nasser K Altorki

http://www.w3.org/2001/XMLSchema#string

Ramon Chua

http://www.w3.org/2001/XMLSchema#string

Sacha Gnjatic

http://www.w3.org/2001/XMLSchema#string

P304

8055-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1536679

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1078-0432.CCR-05-1203

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16299236

http://www.w3.org/2001/XMLSchema#string